glp 1 side effects eyes GLP-1 Medications and Your Vision: What You Should Know GLP-1 Drugs and Diabetic Eye

Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies

Small Molecule GLP-1 Receptor Agonists Segment is Growing at the Highest Rate in the Oral Non-Peptide GLP-1 Receptor Agonist Market The market for the small molecule GLP-1 receptor agonists category was dominant in 2025 due to the numerous developments made in medicinal chemistry and the drug discovery industry

Referred to as the 'Barbie drug' or 'tan jab', Melanotan II stimulates melanin production, resulting in a strong tan without the need to expose oneself to the sun's rays for hours on end

In the meantime, companies that proactively secure capacity and work with manufacturing partners able to scale will be best positioned to succeed